Filter Results:
(3,381)
Show Results For
- All HBS Web
(3,381)
- People (9)
- News (695)
- Research (2,163)
- Events (34)
- Multimedia (26)
- Faculty Publications (1,256)
Show Results For
- All HBS Web
(3,381)
- People (9)
- News (695)
- Research (2,163)
- Events (34)
- Multimedia (26)
- Faculty Publications (1,256)
- 22 Sep 2017
- News
Turning a Disorder into an Opportunity
that are ideal for testing software as well as for working in cybersecurity and analytics. “These employees have found errors, faults, and gaps in IT systems that have gone undetected for years,” Fieldhouse says, adding Dandelion has been... View Details
- 04 Sep 2014
- News
Our focus was to get drug companies to invest money in ALS
could convince them that ALS is a good investment, market forces will do more than all the ALS foundations worldwide can do.” In 2011 and 2012, Prize4Life awarded million-dollar prizes for tests that measure the disease’s progression... View Details
- 12 Nov 2015
- Research & Ideas
Can Consumers be Trusted with Their Own Health Care?
and a profile that varies by situation and according to the patient’s life stage.” Patient Empowerment Taken Too Far? As an example of patient empowerment—and a glimpse at its potential problems—Quelch talked about taking the 23andMe test, a saliva-based... View Details
- September 2020
- Case
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details
Keywords: Vaccines; COVID-19 Pandemic; Health Pandemics; Health Testing and Trials; Innovation and Management; Innovation Strategy; Technological Innovation; Business Strategy; Product Launch; Pharmaceutical Industry
Shih, Willy C. "Merck: COVID-19 Vaccines." Harvard Business School Case 621-028, September 2020.
- 11 Dec 2014
- News
Revolutionizing digital medical records
coordinated, and lower-cost care. Bushkin expects MedKaz to revolutionize health care, bringing about changes in care quality and facilitating changes in the way care is delivered. With it, doctors can avoid medical mistakes and unnecessary View Details
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
- Portrait Project
Drew Johnson
you served them in their moment of greatest need. Through our actions we can do things that transcend the test of time—actions that stand up to any storm. View Details
- 01 Jun 2000
- News
Going Public
sense of excitement on campus these days is palpable as this year's graduates prepare to test their newly acquired skills and ideas in a universe of expanding innovation and opportunity, the likes of which the world has not witnessed for... View Details
- 24 Apr 2014
- News
Transforming the way the social sector innovates, learns, and improves
In Zambia and Uganda, it partnered with the Clinton Health Access Initiative and the Ministries of Health to test new policies in HIV, malaria, and maternal health. IDinsight has also worked in Cambodia and Rwanda and in other sectors... View Details
- 11 Apr 2017
- Blog Post
Why I Love My Job: Andrew Grochal on His Path to CarGurus
side of the business, working closely with each department across the entire company including sales, customer success, engineering and marketing. I lead a team of product managers and we all collaborate with engineering to prioritize ideas, develop those ideas into... View Details
Keywords: Technology
- 21 Sep 2011
- Research & Ideas
Gender and Competition: What Companies Need to Know
2011, using cooperative and competitive scenarios in which participants performed both a verbal and a math test at Harvard Business School's Computer Lab for Experimental Research. Each participant was given a pseudonym, with women... View Details
Keywords: by Kim Girard
- 04 Apr 2018
- Op-Ed
Op-Ed: Why Private Investors Must Fund 'New Nuclear' Power Right Now
nuclear designs are subject to rigorous casualty testing and national licensing, there is no reason to think of nuclear power any differently than we think of other technologies and their use in civil society, such as civil aircraft and... View Details
- 06 Jun 2023
- Blog Post
Van den Ende Rozen: Greenhouse Rose Production
2.5 weeks). Count the petals, are there really 60? Image source: The authors. Five years ago, the brothers started to test the optimal intensity and spectrum of LED lighting on rose cultivation in an experimental site, recognizing that... View Details
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
Schinecker, CEO of Roche Diagnostics, leads a company that received the FDA’s first emergency use authorization for a commercially developed COVID-19 test on March 13. Roche now believes it can ship up to 400,000 View Details
- 31 May 2016
- First Look
May 31, 2016
have a higher probability of walking by the clinic for reasons other than vaccination. Method: We obtained data from an employer with a free workplace influenza vaccination clinic. Using each employee’s building entry/exit swipe card data, we View Details
Keywords: Sean Silverthorne
- Profile
Avi Kremer
could convince them that ALS is a good investment, market forces will do more than all the ALS foundations worldwide can do.” In 2011 and 2012, Prize4Life awarded million-dollar prizes for tests that measure the disease’s progression... View Details
- Portrait Project
Valentina Zarya
ended in puberty, but my hair tells the real story. It’s been a dozen different colors over the years: Raven black during a goth phase in high school; varying shades of copper in college; and blonde to test the “they have more fun”... View Details
- July 2021 (Revised July 2022)
- Case
Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care
By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab
Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’... View Details
Keywords: Health Care and Treatment; Outcome or Result; Cost Management; Activity Based Costing and Management; Mobile and Wireless Technology; Health Testing and Trials; Surveys; Health Industry; Boston
Kaplan, Robert S., Navraj S. Nagra, and Syed S. Shehab. "Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care." Harvard Business School Case 122-010, July 2021. (Revised July 2022.)
- Profile
Allie Corless
of playing to my strengths in shaping my career path. My experience at HBS among my peers and in the classroom was ideal for testing my weaknesses; post-graduation, my understanding of my strengths is helping me to decisively build my... View Details
- 01 Dec 2003
- News
Alumni Author: Thomas H. Fischgrund (MBA ’80)
score 1600? It is the top score. There are 138 questions on the test. You can miss one or two and still score 1600. What percentage of students score 1600? Each year, 2.3 million kids take the test and 650 score 1600 — that’s .03 percent!... View Details